Recurrent Pancreatic Carcinoma Completed Phase 1 Trials for Vorinostat (DB02546)

Also known as: Pancreatic carcinoma recurrent / Pancreas carcinoma recurrent / Pancreatic cancer recurrent

IndicationStatusPhase
DBCOND0043478 (Recurrent Pancreatic Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02349867Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic CancerTreatment